Investigation into FMC Corporation Securities Fraud
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy FMC?
Source: PRnewswire
- Investigation Launched: Pomerantz LLP is investigating whether FMC Corporation and its executives have engaged in securities fraud or other unlawful business practices, aiming to protect investor rights and potentially initiate a class action lawsuit.
- Financial Warning: FMC's revenue guidance for 2026 is set at $3.6 billion to $3.8 billion, reflecting a 5% decline at the midpoint compared to the previous year, while adjusted EBITDA is expected to be between $670 million and $730 million, a 17% drop primarily due to lower prices.
- Stock Price Plunge: On February 5, 2026, FMC's stock price fell by $3.32, or 19.54%, closing at $13.67 per share, indicating market concerns regarding the company's financial outlook.
- Strategic Options Exploration: The FMC Board has authorized the exploration of strategic options, including the potential sale of the company, demonstrating the company's determination to restructure and transform in the face of financial challenges.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FMC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FMC
Wall Street analysts forecast FMC stock price to rise
14 Analyst Rating
3 Buy
10 Hold
1 Sell
Hold
Current: 14.740
Low
13.00
Averages
19.08
High
28.00
Current: 14.740
Low
13.00
Averages
19.08
High
28.00
About FMC
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Price Decline: FMC Corporation's stock has plummeted over 60% in the past year due to tariffs and rising costs, creating significant financial pressure and necessitating careful risk assessment by investors regarding future operations.
- Exploration of Strategic Options: The company's board has authorized the exploration of strategic options, including the potential sale of the company, raising alarms among investors as such a move could drastically impact shareholder returns and increase future uncertainty.
- Deteriorating Financial Performance: Last year, FMC reported a net loss exceeding $2.2 billion, a stark contrast to the previous year's profit of $341.6 million, indicating the company's vulnerability amid market challenges, with projected declines in revenue and adjusted earnings for this year.
- Increased Investment Risks: While FMC's stock may appear cheap, the combination of poor financial results and the possibility of a company sale significantly heightens investment risks, potentially leading to greater losses for investors despite the low stock price.
See More
- Quarterly Dividend Announcement: FMC has declared a quarterly dividend of $0.08 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain stable cash flow, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 2.17% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in FMC's stock.
- Financial Strategy: FMC outlines a plan to reduce $1 billion in debt while projecting sales between $3.6 billion and $3.8 billion for 2026, indicating proactive measures to optimize its financial structure in response to market challenges.
- Market Outlook: FMC will present its strategic direction at the upcoming Bank of America 2026 Global Agriculture and Materials Conference, highlighting the company's long-term growth potential in the agriculture and materials sectors, despite the high-risk nature of the fertilizers market.
See More
- Quarterly Dividend Announcement: FMC Corporation's board of directors has declared a quarterly dividend of 8 cents per share, payable on April 16, 2026, to shareholders of record as of March 31, 2026, demonstrating the company's ongoing commitment to shareholder returns.
- Record Date for Shareholders: The record date for the dividend payment is March 31, 2026, ensuring that investors holding shares before this date will receive the dividend, reflecting the company's strong management of cash flow and shareholder interests.
- Company Background: FMC is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber, and fuel in a changing environment, highlighting its strategic importance and market impact in the agricultural sector.
- Innovative Solutions: FMC's innovative crop protection solutions, including biologicals and precision agriculture, assist growers in addressing challenges, showcasing the company's efforts in promoting sustainable agriculture and environmental protection.
See More
- New Board Appointment: FMC Corporation announced the election of Michael F. Barry to its Board of Directors effective February 27, 2026, where he will serve on the Audit and Compensation and Human Capital committees, expected to bring valuable industry experience and strategic insights to the company.
- Extensive Industry Experience: Barry has over 30 years of global leadership experience in the specialty chemicals sector, having served as CEO of Quaker Houghton, where he grew revenue from $451 million in 2009 to $1.8 billion in 2021, demonstrating his exceptional leadership capabilities.
- Strategic Acquisition Success: Under Barry's leadership, Quaker Houghton completed 27 strategic acquisitions, notably the 2019 merger with Houghton International, which doubled the company's revenue and global footprint, enhancing its competitiveness in the industrial process fluids market.
- Commitment to Long-term Value Creation: Barry expressed his eagerness to collaborate with FMC's Board and management team to create long-term value for shareholders, customers, and employees at this pivotal juncture for the company, indicating his confidence in the company's future growth prospects.
See More
- New Board Member: FMC Corporation announced the election of Michael F. Barry to its Board of Directors effective February 27, 2026, where he will serve on the Audit and Compensation and Human Capital committees, expected to bring valuable industry experience and strategic insights to the company.
- Extensive Industry Experience: Barry has over 30 years of global leadership experience in the specialty chemicals sector, having served as CEO of Quaker Houghton, where he grew revenue from $451 million in 2009 to $1.8 billion in 2021, demonstrating his exceptional leadership capabilities.
- Strategic Transformation Leader: Under Barry's leadership, Quaker Houghton completed 27 strategic acquisitions, notably the 2019 merger with Houghton International, which doubled the company's revenue and global footprint, enhancing its competitiveness in the industrial process fluids sector.
- Commitment to Long-term Value Creation: Barry expressed his eagerness to collaborate with FMC's board and management team to create long-term value for shareholders, customers, and employees at this pivotal moment for the company, indicating his confidence in its future growth prospects.
See More
- Executive Order Backlash: Trump's executive order to boost domestic glyphosate production, despite its cancer links and EPA's safety claims, has sparked strong opposition from the MAHA movement, potentially undermining his support base ahead of the midterm elections.
- Democrats Seize Opportunity: Democrats see Trump's actions as a chance to reclaim MAHA support, with Rep. Chellie Pingree pushing legislation to revoke the order, emphasizing the importance of healthy diets and environmental protection, which could resonate with voters in the upcoming elections.
- Internal MAHA Fractures: Supporters of the MAHA movement express disappointment in Trump's policies, particularly independents and cross-party Democrats who once supported Kennedy, raising concerns about diminished influence in the midterms and potential voter attrition.
- Chemical Regulation Controversy: The Trump administration's alignment with Bayer-Monsanto on glyphosate, supporting weakened litigation against chemical manufacturers, may erode public trust in the government and intensify calls for stricter chemical usage regulations.
See More








